The effect of standardized Echinacea purpurea extract on rat cytochrome P450 expression level

Phytomedicine

Volumn 17, Issue 10, 2010, Pages 830-833

  Mrozikiewicz, P M ^a,b   Bogacz, A ^a,b   Karasiewicz, M ^b   Mikolajczak, P L ^a,b   Ozarowski, M ^a,b   Seremak Mrozikiewicz, A ^a   Czerny, B ^b,c   Bobkiewicz Kozlowska, T ^a   Grzeskowiak, E ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF NATURAL FIBRES AND MEDICINAL PLANTS   (Poland)

^c POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Cytochrome P450; Echinacea purpurea; Expression level; Herb drug interactions; Rat model

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 2D1; ECHINACEA PURPUREA EXTRACT; MESSENGER RNA; POLYPHENOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DNA SYNTHESIS; LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION;

ANIMALIA; ECHINACEA PURPUREA; RATTUS;

EID: 78049323193     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2010.02.007     Document Type: Article

References (26)

1. Bachmann, K.A., Lewis, J.D., Fuller, M.A., Bonfiglio, M.F., 2004. Drug Interactions Handbook. A Complete Guide to Cytochrome P450 Enzyme Substrates, Inducers, and Inhibitors. The New Standard for Evaluating Drug and Herbal Interactions 2nd edition Lexi-Comp, Inc, Hudson, OH.
2. Barnes, J., Anderson, L.A., Gibbons, S., Phillipson, J.D., 2005. Echinacea species (Echinacea angustifolia DC.) Hell., Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L. Moench): a review of their chemistry, pharmacology and clinical properties. J. Pharm. Pharmacol. 57 (8), 929-954.
3. Barrett, B., 2003. Medicinal properties of Echinacea: a critical review. Phytomed 10, 66-86.
4. Ding, X., Kaminsky, L.S., 2003. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol. Toxicol. 43, 149-173.
5. ESCOP Monographs on the medicinal use of plant drugs. The Scientific Foundation for Herbal Medicinal Products. Echinaceae purpureae herba and Echinaceae purpureae radix. European Scientific Cooperative on Phytotherapy, 2th ed. Completely revised and expanded, Exeter, United Kingdom, Georg Thieme Verlag, Thieme, New York, 2003, pp. 129-142.
6. Freeman, C., Spelman, K., 2008. A critical evaluation of drug interactions with Echinacea spp. Mol. Nutr. Food Res. 52, 789-798.
7. Gervasini, G., Carrillo, J.A., Benitez, J., 2004. Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: modulation by endogenous compounds. Clin. Pharmacokinet 43, 693-706.
8. Gonzalez, F.J., Tukey, R.H., 2006. Drug metabolism. In: Brunton, L.L., Lazo, J.S., Parker, K.L. (Eds.), Goodman & Gilman's: The Pharmacological Basis of Therapeutics. McGraw-Hill, New York, pp. 71-91.
9. Hansel, R., Keller, K., Rimpler, H., Schneider, G., 1993. Echinacea, Hagers Handbuch der pharmazeutischen Praxis. Bd. 5. Drogen E.-O. Springer-Verlag, Berlin, Heidelberg, pp. 1-34.
10. Hedlund, E., Gustafsson, J.A., Warner, M., 2001. Cytochrome P450 in the brain: a review. Curr. Drug Metab. 2, 245-263.
11. Hellum, B.H., Hu, Z., Nilsen, O.G., 2007a. The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes. Basic Clin. Pharmacol. Toxicol. 100, 23-30.
12. Hellum, B.H., Nilsen, G., 2008. In vitro inhibiotion of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products. Basic Clin. Pharmacol. Toxicol. 102, 466-475.
13. Hellum, B.H., Nilsen, G., 2007b. The in vitro inhibitory potential of trade herbal products on human CYP2D6-mediated metabolism and the influence of ethanol. Basic Clin. Pharmacol. Toxicol. 101, 350-358.
14. Ioannides, C., 2002. Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica 32, 451-478.
15. Linde, K., Barrett, B., Bauer, R., Melchart, D., Woelkart, K., 2009. Echinacea for preventing and treating the common cold. Cochrane Library Issue 4.
16. Lohr, J.W., Willsky, G.R., Acara, M.A., 1998. Renal drug metabolizm. Pharmacol. Rev. 50, 107-141.
17. Matthias, A., Gillam, E.M.J., Penman, K.G., Matovic, N.J., Bone, K.M., DeVoss, J.J., Lehmann, R.P., 2005. Cytochrome P450 enzyme-mediated degradation of Echinacea alkylamides in human liver microsomes. Chem.-Biol. Interact. 155, 62-70.
18. Meijerman, I., Beijnen, J.H., Schellens, J.H.M., 2006. Herb-drug interactions in oncology: focus on mechanisms of induction. Oncologist 11, 742-752.
19. Michaud, J., Dube, P., Naud, J., Leblond, F.A., Desbiens, K., Bonnardeaux, A., Pichette, V., 2005. Effects of serum form patiens with chronic renal failure on rat hepatic cytochrome P450. Br. J. Pharmacol. 144, 1067-1077.
20. Minn, A.L., Pelczar, H., Denizot, C., Martinet, M., Heydel, J.M., Walther, B., Minn, A., Goudonnet, H., Yves, A., 2005. Characterization of microsomal cytochrome P450-dependent monooxygenases in the rat olfactory mucosa. Drug Metab. Dispos. 33, 1229-1237.
21. Nebert, D.W., Russell, D.W., 2002. Clinical importance of the cytochromes P450. Lancet 360, 1155-1162.
22. Newall, C.A., Anderson, L.A., Philipson, J.D., 1996. Herbal medicines, A Guide for Health-Care Professionals. The Pharmaceutical Press, pp. 101-103.
23. Oinonen, T., Lindros, K.O., 1995. Hormonal regulation of the zonated expression of cytochrome P-450 3A in rat liver. Biochem. J. 309, 55-61.
24. Raner, G.M., Cornelious, S., Moulick, K., Wang, Y., Mortenson, A., Cech, N.B., 2007. Effects of herbal products and their constituents on human cytochrome P4502E1 activity. Food Chem. Toxiocol. 45, 2359-2365.
25. Seliskar, M., Rozman, D., 2007. Mammalian cytochromes P450-importance of tissue specificity. Biochim. Biophys. Acta 1770, 458-466.
26. Zuber, R., Anzenbacherova, E., Anzenbacher, P., 2002. Cytochromes P450 and experimental models of drug metabolism. J. Cell Mol. Med. 6, 189-198.